Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
BioNews - BioPortfolio's News Portal
Oncology and Cancer News and Headlines
Sign-up to BioPortfolio's
Oncology and Cancer news alerts
.
Subscribe to
Oncology&Cancer RSS feed
-
-
View full RSS Index
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Full Article
Genetic Engineering News:
similar ...
VTE risk varies with cancer site
MedWire News:
similar ...
Full Tutorial
Genetic Engineering News:
similar ...
Full Article
Genetic Engineering News:
similar ...
Nereus Pharmaceuticals Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors
Freshnews.com:
similar ...
Nereus Pharmaceuticals Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors
Freshnews.com:
similar ...
EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
NewsBlaze:
similar ...
Emerging Firms Highlighted at Roth Meeting
Genetic Engineering News:
similar ...
Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
SmartBrief:
similar ...
Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
KLFY:
similar ...
Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
Financials.com:
similar ...
Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
KOTA Territory News:
similar ...
Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
Forbes.com:
similar ...
COMMUNIQUE: PR Newswire: Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceuti
Belga Direct Press Releases:
similar ...
New Anti-MMP Antibodies Introduced by AnaSpec
Pharma Live:
similar ...
Phase II Study of IMC-A12 for Advanced Head and Neck Cancer Commences Patient Enrollment
Pharma Live:
similar ...
Phase II Study of IMC-A12 for Advanced Head and Neck Cancer Commences Patient Enrollment
SmartBrief:
similar ...
Phase II Study of IMC-A12 for Advanced Head and Neck Cancer Commences Patient Enrollment
Genetic Engineering News:
similar ...
Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting
Genetic Engineering News:
similar ...
Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting
Genetic Engineering News:
similar ...
